Safety of Pegfilgrastim (Neulasta) in Patients with Sickle Cell Trait/Anemia
Pegfilgrastim (Neulasta) is a recombinant filgrastim (human granulocyte colony-stimulating factor (G-CSF)) attached to a polyethylene glycol (PEG) molecule and is given as part of chemotherapy regimens that are associated with significant myelosuppression and risk for febrile neutropenia. Prescribin...
Saved in:
Main Authors: | Pashtoon Murtaza Kasi, Mrinal M. Patnaik, Prema P. Peethambaram |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2013-01-01
|
Series: | Case Reports in Hematology |
Online Access: | http://dx.doi.org/10.1155/2013/146938 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The Use of Intravenous Neostigmine in Palliation of Severe Ileus
by: Pashtoon Murtaza Kasi
Published: (2013-01-01) -
Malignant Hyperthermia and Idiopathic HyperCKemia
by: Pashtoon Murtaza Kasi
Published: (2011-01-01) -
Outcome of pregnancy in sickle cell anemia patients with COVID-19 infection
by: Vaidyanathan Gowri, et al.
Published: (2024-01-01) -
Cardiovascular Characterization of Children and Adolescents with Sickle Cell Anemia
by: Nancy González Vales, et al.
Published: (2020-02-01) -
Role of Extracellular Hemoglobin in Thrombosis and Vascular Occlusion in Patients with Sickle Cell Anemia
by: Zhou Zhou, et al.
Published: (2011-01-01)